| | Other Issues: previous | next | latest | archiveViewpoint Osteopontin: a new role for a familiar actor Nicholas IF Johnston and Mohamed K El-Tanani PMCID: PMC2656892 Research Articles A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer Fabien Reyal, Martin H van Vliet, Nicola J Armstrong, Hugo M Horlings, Karin E de Visser, Marlen Kok, Andrew E Teschendorff, Stella Mook, Laura van 't Veer, Carlos Caldas, Remy J Salmon, Marc J van de Vijver, and Lodewyk FA Wessels PMCID: PMC2656909 Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulation Christian Perotti, Ruixuan Liu, Christine T Parusel, Nadine Böcher, Jörg Schultz, Peer Bork, Edith Pfitzner, Bernd Groner, and Carrie S Shemanko PMCID: PMC2656886 IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines XingWu Zhu, Lori A Mulcahy, Rabab AA Mohammed, Andrew HS Lee, Hester A Franks, Laura Kilpatrick, Acelya Yilmazer, E Claire Paish, Ian O Ellis, Poulam M Patel, and Andrew M Jackson PMCID: PMC2656888 ErbB3 is required for ductal morphogenesis in the mouse mammary gland Amy J Jackson-Fisher, Gary Bellinger, Jerrica L Breindel, Fatteneh A Tavassoli, Carmen J Booth, James K Duong, and David F Stern PMCID: PMC2656891 A functional Notch–survivin gene signature in basal breast cancer Connie W Lee, Karl Simin, Qin Liu, Janet Plescia, Minakshi Guha, Ashraf Khan, Chung-Cheng Hsieh, and Dario C Altieri PMCID: PMC2656893 Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies Linda E Kelemen, Fergus J Couch, Shahana Ahmed, Alison M Dunning, Paul DP Pharoah, Douglas F Easton, Zachary S Fredericksen, Robert A Vierkant, V Shane Pankratz, Ellen L Goode, Christopher G Scott, David N Rider, Xianshu Wang, James R Cerhan, and Celine M Vachon PMCID: PMC2656894 Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells Anna L Stratford, Christopher J Fry, Curtis Desilets, Alastair H Davies, Yong Y Cho, Yvonne Li, Zigang Dong, Isabelle M Berquin, Philippe P Roux, and Sandra E Dunn PMCID: PMC2656895 PAI-1 and functional blockade of SNAI1 in breast cancer cell migration Elizabeth Fabre-Guillevin, Michel Malo, Amandine Cartier-Michaud, Hector Peinado, Gema Moreno-Bueno, Benoît Vallée, Daniel A Lawrence, José Palacios, Amparo Cano, Georgia Barlovatz-Meimon, and Cécile Charrière-Bertrand PMCID: PMC2656896 Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells Bérengère Marty, Virginie Maire, Eléonore Gravier, Guillem Rigaill, Anne Vincent-Salomon, Marion Kappler, Ingrid Lebigot, Fathia Djelti, Audrey Tourdès, Pierre Gestraud, Philippe Hupé, Emmanuel Barillot, Francisco Cruzalegui, Gordon C Tucker, Marc-Henri Stern, Jean-Paul Thiery, John A Hickman, and Thierry Dubois PMCID: PMC2656897 Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study Thomas P Ahern, Timothy L Lash, Henrik T Sørensen, and Lars Pedersen PMCID: PMC2656898 Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells Annabel C Borley, Stephen Hiscox, Julia Gee, Chris Smith, Victoria Shaw, Peter Barrett-Lee, and Robert I Nicholson PMCID: PMC2656899 Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis Joan S Lewis-Wambi, Helen R Kim, Chris Wambi, Roshani Patel, Jennifer R Pyle, Andres J Klein-Szanto, and V Craig Jordan PMCID: PMC2656901 Proteomic analysis of tumor necrosis factor-α resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype Changhua Zhou, Ashley M Nitschke, Wei Xiong, Qiang Zhang, Yan Tang, Michael Bloch, Steven Elliott, Yun Zhu, Lindsey Bazzone, David Yu, Christopher B Weldon, Rachel Schiff, John A McLachlan, Barbara S Beckman, Thomas E Wiese, Kenneth P Nephew, Bin Shan, Matthew E Burow, and Guangdi Wang PMCID: PMC2656902 Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide Kannan Krishnamurthy, Guanghu Wang, Dmitriy Rokhfeld, and Erhard Bieberich PMCID: PMC2656903 The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer Chantal C Orgéas, Per Hall, Lena U Rosenberg, and Kamila Czene PMCID: PMC2656904 The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer William Tapper, Victoria Hammond, Sue Gerty, Sarah Ennis, Peter Simmonds, Andrew Collins, the Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH) Steering Group, and Diana Eccles PMCID: PMC2656905 EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer Alexandra M Pietersen, Hugo M Horlings, Michael Hauptmann, Anita Langerød, Abderrahim Ajouaou, Paulien Cornelissen-Steijger, Lodewijk F Wessels, Jos Jonkers, Marc J van de Vijver, and Maarten van Lohuizen PMCID: PMC2656906 Reviews Local control by radiotherapy: is that all there is? Silvia C Formenti and Sandra Demaria PMCID: PMC2656907 Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda Bettina Meiser, Kathy Tucker, Michael Friedlander, Kristine Barlow-Stewart, Elizabeth Lobb, Christobel Saunders, and Gillian Mitchell PMCID: PMC2656887 Eph receptors in breast cancer: roles in tumor promotion and tumor suppression David Vaught, Dana M Brantley-Sieders, and Jin Chen PMCID: PMC2656900 Editorials PGRMC1: a new biomarker for the estrogen receptor in breast cancer Rolf J Craven PMCID: PMC2656908 Putative growth characteristics of micrometastatic breast cancer Ann F Chambers and Paul E Goss PMCID: PMC2656890 Approaches towards expression profiling the response to treatment Andrew H Sims and John MS Bartlett PMCID: PMC2656889 |
